228 related articles for article (PubMed ID: 32058466)
1. Proton Pump Inhibitors, But Not H2-receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients.
Lyu B; Jorgenson MR; Hansen KE; Djamali A; Astor BC
Transplantation; 2020 Dec; 104(12):2609-2615. PubMed ID: 32058466
[TBL] [Abstract][Full Text] [Related]
2. Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
Lyu B; Hansen KE; Jorgenson MR; Astor BC
Am J Nephrol; 2020; 51(6):433-441. PubMed ID: 32485707
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case-control study.
Miyano S; Michihata N; Sada KE; Uda K; Matsui H; Fushimi K; Nangaku M; Yasunaga H
Rheumatology (Oxford); 2021 Apr; 60(4):1717-1723. PubMed ID: 33067623
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: risk of fractures with acid-suppressing medication.
Kwok CS; Yeong JK; Loke YK
Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
[TBL] [Abstract][Full Text] [Related]
5. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.
Vangala C; Niu J; Lenihan CR; Mitch WE; Navaneethan SD; Winkelmayer WC
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1534-1541. PubMed ID: 30262672
[TBL] [Abstract][Full Text] [Related]
7. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis.
Mohammadi K; Yaribash S; Razi B; Dashti-Khavidaki S
J Clin Pharm Ther; 2022 May; 47(5):567-574. PubMed ID: 34931328
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients.
Lenihan CR; Sukumaran Nair S; Vangala C; Ramanathan V; Montez-Rath ME; Winkelmayer WC
Am J Kidney Dis; 2017 May; 69(5):595-601. PubMed ID: 27866965
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Histamine Receptor Antagonists Versus Proton Pump Inhibitor Gastrointestinal Ulcer Prophylaxis in Kidney Transplant Recipients.
Rouse GE; Hardinger K; Tsapepas D; Tichy EM
Prog Transplant; 2017 Mar; 27(1):4-9. PubMed ID: 27650918
[TBL] [Abstract][Full Text] [Related]
10. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
11. Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine-2 Receptor Antagonists.
Patel KS; Stephany BR; Barnes JF; Bauer SR; Spinner ML
Pharmacotherapy; 2017 Dec; 37(12):1507-1515. PubMed ID: 28976570
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
Corley DA; Kubo A; Zhao W; Quesenberry C
Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
[TBL] [Abstract][Full Text] [Related]
13. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
14. Early Acid Suppression Therapy Exposure and Fracture in Young Children.
Malchodi L; Wagner K; Susi A; Gorman G; Hisle-Gorman E
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31175146
[TBL] [Abstract][Full Text] [Related]
15. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
[TBL] [Abstract][Full Text] [Related]
16. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitor Use, H
Paik JM; Rosen HN; Gordon CM; Curhan GC
Calcif Tissue Int; 2018 Oct; 103(4):380-387. PubMed ID: 29754277
[TBL] [Abstract][Full Text] [Related]
18. The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study.
Douwes RM; Gomes-Neto AW; Eisenga MF; Van Loon E; Schutten JC; Gans ROB; Naesens M; van den Berg E; Sprangers B; Berger SP; Navis G; Blokzijl H; Meijers B; Bakker SJL; Kuypers D
PLoS Med; 2020 Jun; 17(6):e1003140. PubMed ID: 32542023
[TBL] [Abstract][Full Text] [Related]
19. Acid-suppressive medications and risk of bone loss and fracture in older adults.
Yu EW; Blackwell T; Ensrud KE; Hillier TA; Lane NE; Orwoll E; Bauer DC
Calcif Tissue Int; 2008 Oct; 83(4):251-9. PubMed ID: 18813868
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
